Skip to content
Bored Studies
Recruiting

A Study of the Sleepnet Elara APAP Device

Sleepnet Corporation · NCT07559708

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Not applicable
Target enrollment
55
US sites recruiting
2
Study start
April 21, 2026
Record last updated
October 27, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this study is to evaluate the effectiveness of the Elara APAP device.

Being studied: Sleepnet Elara Treatment

Conditions: Sleep Apnea - Obstructive

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Body weight ≥ 30kg
  • Willing and able to consent, adhere to study requirements and receive mask treatment
  • ≥ 18 years of age
  • Diagnosed with OSA (Total AHI >15 events/hr) by a practicing physician within the last 6 months. A re-diagnosis may be necessary to establish current baseline AHI in case there has been significant weight change or other co-morbidities since the previous diagnosis (per PI discretion)
  • Currently utilizing an APAP Device for ongoing treatment of OSA

Exclusion Criteria

  • Body weight \< 30kg
  • Female currently bearing a child or intending to become pregnant prior to the sleep study.
  • Have implanted pacemaker, ICD or any other medical device that would interfere with the PSG results or safety of the subject undergoing the study
  • Has pneumothorax, pneumomediastinum
  • Has history of Cerebrospinal fluid leakage, craniocerebral trauma, intracranial trauma or pneumocephalus
  • Ongoing shock from various causes untreated
  • Current epistaxis
  • Non-compliant with APAP usage (\< 4 hours per night on 70% of nights)
  • Upper gastrointestinal bleeding that has not been effectively controlled
  • Has obstructive vocal cord polyps
  • Severe coronary heart disease with left heart failure
  • Acute otitis media inflammation (must be resolved prior to sleep study)
  • Excessive respiratory secretions and cough weakness
  • Weak spontaneous breathing
  • Tracheal intubation (nasal or oral) and tracheotomy
  • Severe nasal congestion from various causes
  • Lung bullae
  • Central sleep apnea index >5 events/hr
  • Have another significant sleep disorder(s) that in the opinion of the investigator would confound the results of the study (e.g. periodic leg movements >15/hr or insomnia that would interfere with completing the sleep study).

Recruiting US locations

  • University Sleep Disorders Center

    Auburn, AL 36832

    Site contact: Jessica Grossmann · 205-643-2401 · jgrossmann@medocationresearch.com

  • Clayton Sleep Institute

    St Louis, MO 63123

    Site contact: Matthew Uhles, MS, RPSGT, RST · 314-645-5855 · uhlesm@claytonsleep.com

Study contacts (from the official record)

  • Andrea Brown, M.S. · 408-881-2611 · abrown@abioclinical.com
All sleep studies in Alabama →
A Study of the Sleepnet Elara APAP Device (NCT07559708) | Bored Studies